NAMS
NewAmsterdam Pharma Co N.V.Company with tickers: NAMS, NAMSW
CIK
1936258
CUSIP
N62509109
Shares Outstanding
116,903,979
13F Activity (30d)
153 filings
150 filers
Price
$36.11
Market Cap
$4.22B
P/E Ratio
-20.99
EPS (Diluted)
$-1.72
52W High
$42.21
52W Low
$16.79
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $3,040,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $61,460,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Research & Development | $38,009,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Operating Income | $-58,420,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Net Income | $-48,441,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Basic) | $-0.40 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Diluted) | $-0.40 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |